104 related articles for article (PubMed ID: 21103674)
1. Adherence and knowledge about hyperphosphatemia treatment in hemodialysis patients with hyperphosphatemia.
Nerbass FB; Morais JG; dos Santos RG; Krüger TS; Koene TT; da Luz Filho HA
J Bras Nefrol; 2010; 32(2):149-55. PubMed ID: 21103674
[TBL] [Abstract][Full Text] [Related]
2. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia.
Cupisti A; D'Alessandro C; Baldi R; Barsotti G
J Ren Nutr; 2004 Oct; 14(4):220-5. PubMed ID: 15483782
[TBL] [Abstract][Full Text] [Related]
3. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
[TBL] [Abstract][Full Text] [Related]
4. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G
J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775
[TBL] [Abstract][Full Text] [Related]
5. Daily dietary phosphorus intake variability and hemodialysis patient adherence to phosphate binder therapy.
Tao X; Zhang H; Yang Y; Zhang C; Wang M
Hemodial Int; 2019 Oct; 23(4):458-465. PubMed ID: 31328873
[TBL] [Abstract][Full Text] [Related]
6. Education for dialysis patients lowers long-term phosphate levels and maintains health-related quality of life.
Gardulf A; Pålsson M; Nicolay U;
Clin Nephrol; 2011 Apr; 75(4):319-27. PubMed ID: 21426886
[TBL] [Abstract][Full Text] [Related]
7. Understanding the associations between modifying factors, individual health beliefs, and hemodialysis patients' adherence to a low-phosphorus diet.
Elliott JO; Ortman C; Almaani S; Lee YH; Jordan K
J Ren Nutr; 2015 Mar; 25(2):111-20. PubMed ID: 25282006
[TBL] [Abstract][Full Text] [Related]
8. Challenge of phosphorus control in hemodialysis patients: a problem of adherence?
Arenas MD; Malek T; Gil MT; Moledous A; Alvarez-Ude F; Reig-Ferrer A
J Nephrol; 2010; 23(5):525-34. PubMed ID: 20119931
[TBL] [Abstract][Full Text] [Related]
9. Phosphate binders usage, patients knowledge, and adherence. A cross-sectional study in 4 centers at Qassim, Saudi Arabia.
Aleidi AM; Alayed NJ; Alduraibi HM; Alqassimi NS; Ismail AA
Saudi Med J; 2020 Oct; 41(10):1076-1082. PubMed ID: 33026048
[TBL] [Abstract][Full Text] [Related]
10. [Newly development of phosphate binders in hyperphosphatemic patients with kidney dysfunction].
Negi S; Yamanaka S; Koreeda D; Yashiro M; Shigematsu T
Clin Calcium; 2012 Oct; 22(10):1557-66. PubMed ID: 23023637
[TBL] [Abstract][Full Text] [Related]
11. Hyperphosphatemia among end-stage renal disease patients in developing countries: a forgotten issue?
Afifi A; El-Sayed H; El-Setouhi M; Ahmed H; Khalifa N
Hemodial Int; 2005 Oct; 9(4):409-15. PubMed ID: 16219062
[TBL] [Abstract][Full Text] [Related]
12. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance.
Durose CL; Holdsworth M; Watson V; Przygrodzka F
J Am Diet Assoc; 2004 Jan; 104(1):35-41. PubMed ID: 14702581
[TBL] [Abstract][Full Text] [Related]
13. Comparison of dietary compliance and dietary knowledge between older and younger Korean hemodialysis patients.
Park KA; Choi-Kwon S; Sim YM; Kim SB
J Ren Nutr; 2008 Sep; 18(5):415-23. PubMed ID: 18721736
[TBL] [Abstract][Full Text] [Related]
14. Dietary adherence in Hispanic patients receiving hemodialysis.
Morales López C; Burrowes JD; Gizis F; Brommage D
J Ren Nutr; 2007 Mar; 17(2):138-47. PubMed ID: 17321954
[TBL] [Abstract][Full Text] [Related]
15. Improvement of therapeutic compliance in haemodialysis patients with poor phosphorus control and adherence to treatment with binders: COMQUELFOS study.
Dolores Arenas M; Pérez-García R; Bennouna M; Blanco A; Mauricio O; Prados MD; Lerma JL; Luisa Muñiz M; Belén Martín M;
Nefrologia; 2013; 33(2):196-203. PubMed ID: 23364580
[TBL] [Abstract][Full Text] [Related]
16. Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial.
Yin J; Yin J; Lian R; Li P; Zheng J
BMC Nephrol; 2021 Jul; 22(1):243. PubMed ID: 34210293
[TBL] [Abstract][Full Text] [Related]
17. [Management of phosphate in chronic kidney disease--Phosphorus control by hemodialysis with long treatment time].
Tanaka M
Clin Calcium; 2009 Feb; 19(2):194-7. PubMed ID: 19182358
[TBL] [Abstract][Full Text] [Related]
18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
19. Treating mineral metabolism disorders in patients undergoing long hemodialysis: a search for an optimal strategy.
Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Mayor B; Chazot C
Hemodial Int; 2009 Oct; 13(4):526-32. PubMed ID: 19758298
[TBL] [Abstract][Full Text] [Related]
20. [Management of hyperphosphatemia in dialysis patients: the role of phosphate binders].
Malberti F
G Ital Nefrol; 2010; 27 Suppl 52():S47-54. PubMed ID: 21132662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
